Should we also evaluate SET together with CIP2A for the treatment with second-generation tyrosine kinase inhibitors in chronic myeloid leukemia?
Cristóbal, I, Manso, R, González-Alonso, P, Rojo, F, García-Foncillas, JLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2015.201
Date:
August, 2015
File:
PDF, 67 KB
english, 2015